Trivium Point Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,276
Closed -$286K 357
2025
Q2
$286K Sell
3,276
-179
-5% -$14K 0.03% 292
2025
Q1
$236K Buy
3,455
+200
+6% +$16.3K 0.03% 313
2024
Q4
$253K Sell
3,255
-37
-1% -$2.74K 0.03% 306
2024
Q3
$239K Sell
3,292
-496
-13% -$40.7K 0.03% 306
2024
Q2
$429K Sell
3,788
-71
-2% -$8.98K 0.06% 220
2024
Q1
$535K Buy
3,859
+63
+2% +$7.92K 0.12% 153
2023
Q4
$471K Buy
3,796
+53
+1% +$5.41K 0.11% 147
2023
Q3
$340K Buy
3,743
+272
+8% +$30.7K 0.09% 159
2023
Q2
$446K Sell
3,471
-12
-0.3% -$1.45K 0.12% 157
2023
Q1
$405K Hold
3,483
0.11% 157
2022
Q4
$403K Sell
3,483
-448
-11% -$49.2K 0.12% 150
2022
Q3
$374K Sell
3,931
-78
-2% -$6.61K 0.12% 153
2022
Q2
$328K Sell
4,009
-39
-1% -$3.56K 0.1% 165
2022
Q1
$516K Buy
4,048
+320
+9% +$35K 0.11% 170
2021
Q4
$500K Sell
3,728
-24
-0.6% -$3.45K 0.1% 164
2021
Q3
$506K Buy
3,752
+340
+10% +$42.9K 0.12% 152
2021
Q2
$364K Buy
3,412
+396
+13% +$38K 0.09% 169
2021
Q1
$271K Buy
3,016
+608
+25% +$57.1K 0.07% 176
2020
Q4
$233K Buy
+2,408
New +$215K 0.07% 172

Other funds holding DXCM